Turning market volatility into commercial advantage in chemicals
The chemical industry is navigating one of its most complex commercial environments in decades, shaped by volatile raw material prices, energy cost pressures, tightening regulation, and increasingly fragmented demand. Against this backdrop, achieving commercial excellence has become a strategic imperative for chemicals companies, write experts from Stratence Partners.
The list of challenges facing commercial teams in chemicals businesses is extensive. Margin erosion, inconsistent pricing discipline, and limited visibility across regions and customer segments remain persistent issues, even for large, global players. In many organisations, these challenges are not isolated problems but symptoms of deeper structural weaknesses in commercial models and decision-making.
High exposure to input cost volatility continues to put pressure on margins, particularly where price pass-through is delayed or inconsistently applied. At the same time, fragmented pricing governance across regions and product lines often leads to uneven execution, with local teams operating under different rules, tools, and levels of oversight.
These pressures are intensified in commoditised segments, where limited differentiation reduces pricing power and increases reliance on volume-driven strategies. Compounding the issue further, many chemicals businesses lack clear transparency on deal profitability and customer value capture, making it difficult to assess which commercial activities truly create value.
As a result, sales teams are frequently overloaded with complexity and exceptions, spending significant time navigating approvals, discounts, and bespoke arrangements rather than focusing on strategic customer engagement and growth. Over time, this erodes effectiveness, slows decision-making, and limits the ability of commercial teams to respond confidently to market volatility.
Commercial Excellence
In this operating environment, a growing gap is emerging between companies that master their commercial capabilities – driving growth, margins, and profitability – and those that lag the market.
So how can companies set themselves on a path to standing out? The answer lies in combining strategic clarity, pricing excellence, and disciplined commercial execution. From our experience at Stratence Partners, the most resilient players are moving away from traditional approaches such as cost-plus and reactive pricing. Instead, they are embracing structured commercial transformation, focused on four key levers:
Value-based pricing beyond commodities
Even in highly competitive segments, customers value reliability, supply security, formulation expertise and service. Translating these into structured price corridors is critical.
Integrated commercial governance
Strategy, Pricing, Sales and Finance must operate as one system, not as disconnected silos. Clear decision rights and escalation rules are essential.
Data-driven execution at scale
Advanced analytics and AI-enabled tools allow chemical companies to manage thousands of SKUs, customers and contracts with consistency and speed.
Self-funded transformation models
Quick commercial wins can finance longer-term capabilities, avoiding large upfront investments and minimizing organizational resistance.
Conclusion
Commercial excellence in the chemical industry is no longer about isolated pricing projects. It requires a unified framework combining strategy, pricing, governance and execution, supported by technology and senior expertise. Companies that move decisively are not just protecting margins, they are creating sustainable competitive advantage in an increasingly volatile market.
